Market Cap 83.01M
Revenue (ttm) 4.91M
Net Income (ttm) -53.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,080.24%
Debt to Equity Ratio 0.10
Volume 30,900
Avg Vol 66,026
Day's Range N/A - N/A
Shares Out 1.07M
Stochastic %K 66%
Beta 3.57
Analysts Strong Sell
Price Target $230.50

Company Profile

Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, includ...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 655 4168
Address:
611 Gateway Boulevard, Suite 740, South San Francisco, United States
Pepe_sanchez89
Pepe_sanchez89 Feb. 3 at 8:16 PM
$TIRX it was no $SPRB , voices in my head were right
0 · Reply
Heroforest
Heroforest Feb. 3 at 7:44 PM
$SPRB how high usually price go up when we announce the BLA?
0 · Reply
Saaawingaling
Saaawingaling Feb. 3 at 4:47 PM
$SPRB $TIRX that would be Awesome!!!
0 · Reply
Pepe_sanchez89
Pepe_sanchez89 Feb. 3 at 4:44 PM
$TIRX this gives me $SPRB vibes
0 · Reply
Relic_research
Relic_research Jan. 29 at 8:30 AM
$SPRB Trades 18% higher at overnight trading hours, but no news posted yet. Somebody knows something, or im missing some news.
2 · Reply
coolguyawesomeman
coolguyawesomeman Jan. 27 at 11:18 PM
$SPRB I think BLA submission prior/on Jan 30th looks likely still, although not clear whether this would be disclosed on the day of, or during Q-10 fillings Feb 15th, I don't think it would require 8K filling, so company could decide to not to announce until the quarterly fillings. I think given they have had a 2026 Q1 submission and Sept 30th approval timeline planned since mid last year, they would have had some pathway towards actually achieving this, and given there is no new evidence that they might not be able to accomplish this, and the recent debt financing (which, as part of due diligence for that, PROBABLY included the creditor assessing their BLA filling readiness to be sufficient to meet their deadlines). I think it's more likely than not, but who knows, we will see.
1 · Reply
ShakeThatMoneyMaker
ShakeThatMoneyMaker Jan. 27 at 5:13 PM
$SPRB have a bad feeling this isnt going to meet its January catalyst deadline for PRV
1 · Reply
ChartSignal_98
ChartSignal_98 Jan. 26 at 4:46 PM
$SPRB microcap biotech tight range low attention asymmetry into catalysts
0 · Reply
TheBasedTrader
TheBasedTrader Jan. 26 at 2:56 PM
$SPRB adding more here
0 · Reply
topstockalerts
topstockalerts Jan. 26 at 1:00 PM
Pre Market Top Gainers PT2 $YYAI $ABOS $NAMM $BGM $SPRB
0 · Reply
Pepe_sanchez89
Pepe_sanchez89 Feb. 3 at 8:16 PM
$TIRX it was no $SPRB , voices in my head were right
0 · Reply
Heroforest
Heroforest Feb. 3 at 7:44 PM
$SPRB how high usually price go up when we announce the BLA?
0 · Reply
Saaawingaling
Saaawingaling Feb. 3 at 4:47 PM
$SPRB $TIRX that would be Awesome!!!
0 · Reply
Pepe_sanchez89
Pepe_sanchez89 Feb. 3 at 4:44 PM
$TIRX this gives me $SPRB vibes
0 · Reply
Relic_research
Relic_research Jan. 29 at 8:30 AM
$SPRB Trades 18% higher at overnight trading hours, but no news posted yet. Somebody knows something, or im missing some news.
2 · Reply
coolguyawesomeman
coolguyawesomeman Jan. 27 at 11:18 PM
$SPRB I think BLA submission prior/on Jan 30th looks likely still, although not clear whether this would be disclosed on the day of, or during Q-10 fillings Feb 15th, I don't think it would require 8K filling, so company could decide to not to announce until the quarterly fillings. I think given they have had a 2026 Q1 submission and Sept 30th approval timeline planned since mid last year, they would have had some pathway towards actually achieving this, and given there is no new evidence that they might not be able to accomplish this, and the recent debt financing (which, as part of due diligence for that, PROBABLY included the creditor assessing their BLA filling readiness to be sufficient to meet their deadlines). I think it's more likely than not, but who knows, we will see.
1 · Reply
ShakeThatMoneyMaker
ShakeThatMoneyMaker Jan. 27 at 5:13 PM
$SPRB have a bad feeling this isnt going to meet its January catalyst deadline for PRV
1 · Reply
ChartSignal_98
ChartSignal_98 Jan. 26 at 4:46 PM
$SPRB microcap biotech tight range low attention asymmetry into catalysts
0 · Reply
TheBasedTrader
TheBasedTrader Jan. 26 at 2:56 PM
$SPRB adding more here
0 · Reply
topstockalerts
topstockalerts Jan. 26 at 1:00 PM
Pre Market Top Gainers PT2 $YYAI $ABOS $NAMM $BGM $SPRB
0 · Reply
ignoreo
ignoreo Jan. 25 at 9:29 AM
can ICE pls stop gunning down peaceful protestors in the streets? its messing w my homie $SPRB, i just want prv reauth locked and no bla delays
0 · Reply
ShakeThatMoneyMaker
ShakeThatMoneyMaker Jan. 25 at 1:36 AM
$SPRB Are we going to tank on this since the PRV bills havent passed yet?
3 · Reply
1AMBITIOUSSAVAGE
1AMBITIOUSSAVAGE Jan. 23 at 9:36 PM
$BNAI $SPRB QUADRUPLE it!! EQPT
0 · Reply
DennisTex
DennisTex Jan. 22 at 4:04 PM
0 · Reply
Don_Frye
Don_Frye Jan. 21 at 4:45 PM
$SPRB 5k traded all day .. haha
0 · Reply
coolguyawesomeman
coolguyawesomeman Jan. 20 at 9:51 PM
$SPRB PRV program has been added to the minibus spending bill, looking likely to pass the senate next week.
0 · Reply
neelsen01
neelsen01 Jan. 20 at 5:32 PM
$SPRB Adding again at sub $70 level…
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 15 at 11:35 PM
$SPRB Current Stock Price: $74.91
0 · Reply
JFais
JFais Jan. 15 at 12:16 AM
Sorry link for the other post didn't work- fixed it Chicken scratch notes for $XENE $SPRB $ZBIO $CLY https://x.com/jfais20/status/2011592626990952733?s=20
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Jan. 14 at 10:16 PM
$SPRB raise your hand ✋️ if you're holding or waiting for single digits. 💋
1 · Reply
neelsen01
neelsen01 Jan. 13 at 2:37 PM
$SPRB Adding under $75 level…
0 · Reply
ignoreo
ignoreo Jan. 13 at 2:27 AM
$SPRB 1) will be approved before they need to dilute/take on additional debt (2028) 2) will be granted PRV, giving them enough cash to reach cashflow breakeven 3) 200m peak sales is highly reasonable 4) co could be close to a $1B company in as few as ~3 years if things go reasonably well if PRV thesis flops (~20% chance), you still probably get a 2x out of this one
0 · Reply